-
Ward Ogden posted an update 1 week, 6 days ago
Elastomeric chains are of clinical importance to orthodontics. Therefore, their behavior should be assessed under different conditions. Some of their critical aspects remain unstudied (including effects of different elongations and chain forms on their force properties). Therefore, we aimed to assess these factors.
This
study was performed on 540 observations first, 90 chains (10 specimens per subgroup of three brands [American Orthodontics, Ortho Technology (OT), and G&H], each from three chain types [closed, short, and long]) were stretched for three extents (40%, 60%, and 100%) and their forces were measured using a universal testing machine. Afterward, 270 new chains of the same brands/types were stretched for the same extents by installing them onto pairs of pins with different interpin distances. Plates holding pins/chains were incubated in artificial saliva at 37°C for 4 weeks. Afterward, their forces were measured and analyzed using partial correlation coefficient, three-way analysis of var used to stretch for lesser extents.
In this study, the effect of adding purified powder of
on the mechanical properties and bonding ability of resin-modified glass ionomer (RMGI) cement is investigated.
In this
study Purified powder of
with particles smaller than 50 μ, in weight percentages of 0.5%, 0.75%, 1%, and 1.25%, was added to RMGI powder (GC Fuji II LC, GC USA). Fifty samples in five groups of control and percentages that considered, from the powder of GI combined with liquid, according to the manufacturer instructions and prepared samples with 4 mm × 6 mm dimensions and placing in distilled water in an incubator with temperature 37°C for 24 h. Fifty sound extracted upper premolars were collected and divided into five groups. The dentinal cross-sections on the occlusal surfaces of teeth were prepared and assessed under a stereomicroscope with ×16. Then, samples with 2 × 4 dimensions from RMGI was prepared on dentin surface and keeping in moisture environment in an incubator with temperature 37°C for 24 h. Compressive strengmpressive strength and shear bond strength of RMGI cement.Background Difference in dyspnea mMRC ≥2 between Finnish speaking and Swedish-speaking populations in Finland has not been previously studied. Methods In February 2016, a respiratory questionnaire was sent to 8000 randomly selected subjects aged 20-69 years in western Finland with a response rate of 52.3%. The registered native language of each subject determined whether questionnaire in Finnish or Swedish was applied. Multiple logistic regression was performed to calculate Odds Ratios (OR) with 95% CI for the simultaneous effects of independent variables on dyspnea mMRC ≥2. Results Of all participants, 2780 (71.9%) were Finnish speakers and 1084 (28.1%) were Swedish speakers. Finnish speakers had a higher prevalence of dyspnea mMRC ≥2 (11.1% vs 6.5% p 35 (OR = 9.74), asthma (OR = 4.78), female gender (OR = 2.38), older age (OR = 2.20), current smoking (OR = 1.59), and occupational exposure to VGDF (OR = 1.47). Conclusions Swedish speakers had less dyspnea mMRC ≥2 which is explained by a healthier lifestyle. Smoking, obesity, and occupational exposures should be in focus to improve respiratory health.Purpose A international registry analysis led by Mehra et al. to investigate the use of hydroxychloroquine (HCQ) and chloroquine (CQ) with or without a macrolide in 96,032 hospitalised COVID-19 patients were published on Lancet, which has raised considerable discussions in the public health community. This study aimed to critically review the quality and limitations of the Mehra et al. publication and discuss the potential influences on the use of HCQ/CQ worldwide. Method A critical review of this publication was conducted to examine the potential study bias in the study objectives, methodology, confounding factors and outcomes and summarise the external reviews. Results The very high homogeneity of the patients’ characteristics at baseline was inconsistent with region specific epidemiology and several critical confounding factors. The results indicated that angiotensin converting enzyme inhibitors were associated with a hazard ratio of 0.5, which suggested a technical problem in the estimation of the propensity scores. Several major risk factors for mortality identified in the analysis were treated as a minor risk or neutral or even protective factors. Antiviral treatments were recognised as an effective method to reduce mortality and were neither further studied nor integrated in the multivariate Cox model. Conclusion This research appeared to carry multiple biases. An extensive audit of the study, conditions of review and acceptance for publication in the Lancet of that study are requested to avoid damage to the publics’ trust on the scientific community at this critical time of COVID-19 pandemic.Exosomes support cell-to-cell communication in physiology and disease, including cancer. We currently lack tools, such as small chemicals, capable of modifying exosome composition and activity in a specific manner. Building on our previous understanding of how syntenin, and its PDZ partner syndecan (SDC), impact on exosome composition we optimized a small chemical compound targeting the PDZ2 domain of syntenin. In vitro , in tests on MCF-7 breast carcinoma cells, this compound is non-toxic and impairs cell proliferation, migration and primary sphere formation. It does not affect the size or the number of secreted particles, yet it decreases the amounts of exosomal syntenin, ALIX and SDC4 while leaving other exosomal markers unaffected. Interestingly, it also blocks the sorting of EpCAM, a bona fide target used for carcinoma exosome immunocapture. selleck chemical Our study highlights the first characterization of a small pharmacological inhibitor of the syntenin-exosomal pathway, of potential interest for exosome research and oncology.The SARS-CoV-2 virus and its homolog SARS-CoV penetrate human cells by binding of viral spike protein and human angiotensin converting enzyme II (ACE2). SARS-CoV causes high fever in almost all patients, while SARS-CoV-2 does not. Moreover, analysis of the clinical data revealed that the higher body temperature is a protective factor in COVID-19 patients, making us to hypothesize a temperature-dependent binding affinity of SARS-CoV-2 to human ACE2 receptor. In this study, our molecular dynamics simulation and protein surface plasmon resonance cohesively proved the SARS-CoV-2-ACE2 binding was less affinitive and stable under 40 °C (~18 nM) than the optimum temperature 37 °C (6.2 nM), while SARS-CoV-ACE2 binding was not (6.4 nM vs. 8.5 nM), which evidenced the temperature-dependent affinity and explained that higher temperature is related to better clinical outcome. The decreased infection at higher temperature was also validated by pseudovirus entry assay using Vero and Caco-2 cells. We also demonstrated the structural basis of the distinct temperature-dependence of the two coronaviruses.